1/78
Vocabulary practice flashcards covering cell structure, host-pathogen interactions, microbial growth control, medical parasitology, virology, and antimicrobial pharmacology.
Binomial Nomenclature
The formal two-part naming system for living organisms consisting of the Genus name (always capitalized) and the species name (always lowercase), written in italics when typed or underlined when handwritten.

Arrangements of Bacilli
The structural groupings of rod-shaped bacteria, which include single bacilli, oval coccobacilli, paired diplobacilli, chains of streptobacilli, and fence-like side-by-side palisades.
Gram Stain
A differential staining procedure dividing bacteria into Gram-positive and Gram-negative groups based on cell wall composition using crystal violet, iodine mordant, an alcohol decolorizer, and a safranin counterstain.

Bacterial Cell Wall Architecture
Structural distinction where Gram-positive bacteria possess a thick peptidoglycan meshwork embedded with lipoteichoic acid, whereas Gram-negative bacteria possess a thin peptidoglycan layer surrounded by an outer membrane containing lipopolysaccharide (LPS), phospholipids, and porins.
Acid-Fast Stain
A specialized differential laboratory staining technique (Ziehl-Neelsen) utilizing steaming and carbolfuchsin to penetrate and identify bacteria with thick, waxy mycolic acid cell walls, such as Mycobacterium species.
Endospore Stain
A differential laboratory technique using malachite green and safranin counterstain to visualize dormant, highly resistant bacterial survival structures produced by genera such as Bacillus and Clostridium.
Pathogenicity
The qualitative ability or capacity of a microorganism to cause disease in a host organism.
Virulence
The quantitative measurement of the degree of intensity, harmfulness, or disease-producing power of a pathogen within a given group or species.
Normal Flora
The stable, permanent population of microorganisms inhabiting specific body sites in a healthy person—routinely numbering about 1014 bacteria in a human body composed of approximately 1013 cells.
Opportunistic Pathogen
A microorganism that causes disease only when the host innate or adaptive defenses are compromised, or when it gains access to normally sterile body sites.

The Disease Triangle
A conceptual model demonstrating that infectious disease develops only when a virulent pathogen, a susceptible host, and a conducive environment are simultaneously present.

Quorum Sensing
A bacterial cell-to-cell communication mechanism mediated by autoinducer signaling molecules that allows populations to monitor cell density and coordinate collective behaviors such as biofilm formation, bioluminescence, and virulence factor expression.
Biofilm
A structured community of microorganisms adhered to a surface and embedded within a self-produced matrix of highly hydrated extracellular polymeric substances (EPS), providing protection against host immune defenses and antibiotics.
Mucociliary Escalator
A respiratory defense system consisting of ciliated epithelial cells (featuring a 9+2 microtubule arrangement) and mucus that continuously traps and sweeps inhaled particles and pathogens up and out of the conducting airways.
Phagocytosis
A form of endocytosis by which specialized host immune cells, such as neutrophils and macrophages, engulf large foreign particles, dead cells, and invading microbes into internal vesicles for destruction.
Receptor-Mediated Endocytosis
A selective endocytic entry mechanism where specific extracellular molecules or viral surface ligands bind to host cell surface receptors, triggering vesicle invagination and internalization.
Exocytosis
The active cellular transport process whereby intracellular membrane-bound secretory vesicles fuse with the plasma membrane to release contents, such as newly assembled virions or metabolic wastes, into the extracellular environment.
Parenteral Route
A portal of entry for pathogens that bypasses the digestive tract, occurring directly through breaks in the skin or mucous membranes via injections, surgery, bites, or trauma.
Infectious Dose 50 (ID50​)
The number or concentration of pathogen organisms required to establish active infection in 50% of an experimental host population.
Lethal Dose 50 (LD50​)
The number or concentration of pathogen organisms or toxin required to kill 50% of an inoculated host population.
Opsonization
The process by which pathogens are coated with antibodies or complement proteins to facilitate recognition, binding, and ingestion by phagocytic immune cells.
Coagulase
A bacterial bacterial enzyme produced by pathogens such as Staphylococcus aureus that induces blood clot formation around the bacteria to shield them from host defenses.
Streptokinase
A bacterial kinase enzyme produced by streptococci that breaks down fibrin blood clots, facilitating the dissemination of pathogens into surrounding tissues.
Exotoxins
Soluble, toxic proteins synthesized and actively secreted by living bacteria (mostly Gram-positive) into surrounding tissues, classified into cytotoxins, neurotoxins, and enterotoxins.
Endotoxins
The toxic lipid A component of lipopolysaccharide (LPS) located within the outer membrane of Gram-negative bacteria, released primarily when the bacterial cell dies and lyses.
Cytopathic Effects (CPE)
Observable structural and biochemical alterations in host cells induced by viral infection, including cell rounding, syncytia formation, formation of inclusion bodies, and cell lysis.
Etiology
The study or determination of the specific cause or causative agent of a particular disease.
Bacteremia
The clinical condition characterized by the simple presence of viable bacteria circulating within the bloodstream without active multiplication.
Septicemia
A severe, life-threatening systemic clinical condition where bacteria actively multiply in the bloodstream, triggering a dysregulated inflammatory immune response.
Microbial Antagonism
The mechanism by which normal resident microflora inhibit the colonization and overgrowth of competing or pathogenic microorganisms, often through nutrient competition or the secretion of bacteriocins.

Periods of Disease Progression
The typical sequential phases of an infectious disease comprising the incubation period, prodromal period, period of illness (peak severity), period of decline, and period of convalescence.
Latent Disease
An infection in which the causative pathogen remains dormant inside host tissues without causing detectable symptoms, retaining the ability to reactivate and reproduce long after the primary illness.
Persistent Bacterial Infection
A condition in which bacteria survive long-term within host reservoirs without producing acute clinical symptoms, such as Salmonella enterica serovar Typhi persisting inside macrophages and the gallbladder.
Emerging Infectious Diseases
Infections whose incidence in humans has increased in the past 30Â years or threatens to increase in the near future, encompassing newly evolved pathogens or previously unrecognized entities.
Re-Emerging Infectious Diseases
Known diseases that were previously controlled through public health measures or antibiotics but have resurged due to pathogen evolution, antimicrobial resistance, or declining host immunity.
Antigenic Drift
A mechanism of viral variation characterized by the gradual accumulation of minor point mutations in viral genes during replication, resulting in small changes in surface antigens over time.
Antigenic Shift
A major, abrupt genetic alteration occurring when two different viral strains co-infect the same host cell and undergo genetic reassortment, producing novel surface antigen combinations that can lead to pandemics.
Arbovirus
An informal name for any arthropod-borne virus transmitted to vertebrate hosts by vectors such as mosquitoes and ticks, exemplified by the West Nile virus (genus Flavivirus) transmitted by Culex mosquitoes.
Prions
Proteinaceous infectious agents devoid of nucleic acids that induce the abnormal, pathogenic misfolding of normal cellular prion proteins (PrPc to PrPSc) in the brain, causing transmissible spongiform encephalopathies.
Bioterrorism
The intentional release or dissemination of biological agents (bacteria, viruses, or toxins) to cause illness, death, fear, and social disruption in civilian populations.
Capsomere
An individual protein subunit that self-assembles to construct the outer protective viral capsid.
Viral Envelope
A host-derived lipid bilayer acquired during viral budding that embeds viral glycoproteins and surrounds the protein capsid in certain animal viruses.

Viral Lytic Cycle
A reproductive cycle of a virus culminating in the assembly of new virions, host cell lysis, and release of progeny particles into the environment.
Retrovirus
An RNA virus that utilizes the enzyme reverse transcriptase to transcribe its single-stranded RNA genome into complementary DNA, which subsequently integrates into the host chromosome as a provirus.
Cytotoxic T Lymphocyte (CTL) Escape Mutants
Viral variants that accumulate mutations within their immunodominant peptide epitopes, preventing recognition by host cytotoxic T cells and facilitating persistent infection.

Mechanisms of Acquisition of Immunity
Classification of adaptive immunity into four categories: natural passive (maternal antibodies via placenta or breast milk), artificial passive (injected harvested antibodies), natural active (illness and recovery), and artificial active (vaccination).
Oncoviruses
Viruses capable of inducing cancer or tumor formation in host organisms by disrupting normal cell cycle regulation, inactivating tumor suppressors, or stimulating uncontrolled cellular proliferation.
Definitive Host
The specific host organism in which a parasite undergoes sexual reproduction and reaches adult maturity.
Intermediate Host
A host organism that harbors a parasite during its larval development or period of asexual reproduction.
Trophozoite
The active, motile, feeding, and reproducing vegetative life-cycle stage of parasitic protozoa.
Cyst (Protozoan)
A dormant, protective, thick-walled survival form of protozoa that facilitates transmission across hostile environmental conditions.

Entamoeba histolytica
An obligate amoebic protozoan transmitted via the fecal-oral route that exists as an active trophozoite with pseudopods and a spherical infective cyst containing condensed chromatin and up to four nuclei.
Malarial Paroxysm
A synchronized cyclic episode of malaria symptoms caused by the synchronous rupture of infected red blood cells and release of merozoites, featuring a cold shaking chill stage followed by a high-fever hot stage and profuse sweating.
Nematodes
Cylindrical, unsegmented roundworms possessing a tough cellular cuticle, differentiated internal organ systems, and separate sexes, including species like Ascaris lumbricoides and Enterobius vermicularis.
Cestodes
Tapeworms characterized by an attachment scolex (head), a regenerative neck, and flattened reproductive segments called proglottids that absorb nutrients directly across their cuticle.
Trematodes
Flukes with flattened, leaf-shaped, bilaterally symmetrical bodies equipped with an oral sucker for feeding and a distal ventral sucker for attachment to host tissues.
Schistosomiasis
A helminthic infection caused by Schistosoma blood flukes, in which cercariae shed from snail intermediate hosts directly penetrate human skin and migrate to mate permanently in the mesenteric or portal venules.
Disinfection
The use of physical or chemical agents (disinfectants) to reduce or destroy vegetative pathogens on inanimate surfaces and non-living objects.
Antisepsis
The application of chemical agents (antiseptics) to living skin or mucous membranes to inhibit or destroy vegetative microorganisms without damaging host tissues.
Sterilization
The validated, complete destruction or elimination of all viable microorganisms, including vegetative bacterial cells, viruses, fungi, and bacterial endospores.
Degerming
The physical or mechanical removal of microbes from limited surface areas, such as using alcohol swabs or scrubbing with soap and water.
Sanitization
The reduction of microbial populations on public or commercial inanimate objects and facilities to levels considered safe by accepted public health standards.
Ultra-High Temperature (UHT) Processing
A heat sterilization method treating liquids at 284F (140C) for 4Â seconds, destroying virtually all microbes to permit room-temperature storage for up to 6Â months.
Surfactant
An amphipathic chemical compound, such as soap or detergent, possessing polar hydrophilic heads and nonpolar hydrophobic tails that lowers water surface tension and disrupts cellular phospholipid membranes.
Microbial Death
The permanent and irreversible loss of an organism's reproductive capability even under optimal nutritional and environmental growth conditions.

Minimal Inhibitory Concentration (MIC)
The lowest concentration of an antimicrobial chemical or antibiotic that prevents visible in vitro microbial growth following overnight incubation in broth dilution tests.
Thermal Death Time (TDT)
The shortest duration of time required to completely kill all microorganisms in a specific liquid suspension at a defined temperature.
Lyophilization
A preservation method combining rapid freezing with dehydration under high vacuum, allowing long-term storage of viable bacterial cultures without metabolic degradation.
HEPA Filters
High-Efficiency Particulate Air filters engineered to physically trap and remove at least 99.97% of airborne particles, bacteria, and spores measuring 0.3ÎĽm or larger from circulating air.
Ethylene Oxide (EtO)
A highly reactive, penetrating, and sporicidal gaseous chemical agent that sterilizes heat- and moisture-sensitive clinical plastics and instruments through protein and nucleic acid alkylation.
Selective Toxicity
The pharmacological principle wherein an antimicrobial drug inhibits or kills a pathogenic microbe without causing significant injury or toxicity to the eukaryotic host cells.
Beta-Lactam Ring
A core four-membered cyclic amide ring essential for the antimicrobial action of penicillins, cephalosporins, and carbapenems by covalently binding bacterial transpeptidases.
Penicillin-Binding Proteins (PBPs)
Bacterial transpeptidase enzymes responsible for cross-linking adjacent glycan polymers (NAG and NAM) during peptidoglycan cell wall biosynthesis, which serve as the primary binding targets for beta-lactam antibiotics.

Competitive Inhibition by Sulfa Drugs
A metabolic blockade where sulfonamides structurally mimic para-aminobenzoic acid (PABA) to competitively bind the enzyme active site, halting bacterial folic acid synthesis.

Acyclovir
A synthetic nucleoside analog structurally mimicking guanosine that, upon phosphorylation by viral thymidine kinase, competitively inhibits herpesvirus DNA polymerase and terminates growing viral DNA strands because it lacks a 3′-hydroxyl group.
Oseltamivir (Tamiflu)
An oral antiviral neuraminidase (NA) inhibitor that prevents newly formed influenza A and B virions from budding and detaching from infected host cell surfaces, recommended to begin within 48Â hours of symptom onset.
Azoles
A major class of antifungal drugs (including fluconazole and itraconazole) that selectively inhibit the enzyme cytochrome P450 lanosterol 14α-demethylase, preventing the synthesis of ergosterol in fungal plasma membranes.
Echinocandins
A specialized class of antifungal agents that exhibit selective toxicity by inhibiting the synthesis of β-(1,3)-glucan, a critical structural component of the fungal cell wall absent in human cells.
Ivermectin
An antinematodal medication that binds selectively to invertebrate glutamate-gated chloride channels in nerve and muscle cells, leading to chloride ion influx, membrane hyperpolarization, and flaccid parasite paralysis.